There's a certain irony in trying to improve how humans work by strapping cameras to their bodies. But that's precisely the wager SiteVue AI is making.
The Franklin, Tennessee startup has pulled in $7 million in seed funding, according to a Form D filing dated May 13, 2025. The money—its largest infusion yet—will fuel an ambitious pitch: body-worn cameras that promise to reduce workplace injuries and boost productivity, all without asking factory workers to change a thing about their routines.
It's a tall order. Manufacturing floors are notoriously resistant to new technology, especially when it involves surveillance-adjacent gadgets. But SiteVue, founded just last year, believes it has cracked the code with what it calls "operational intelligence for frontline teams." Workers wear small cameras that capture egocentric video—essentially, what they see as they move through assembly lines and workstations. The footage feeds into a dashboard that surfaces cycle times, productivity metrics, and safety compliance data in real time.
The company claims deployment can happen quickly, though these are marketing assertions rather than independently verified benchmarks. Just minutes of training, and you're live, according to SiteVue.
The Numbers Game
SiteVue's website doesn't shy away from bold claims. Productivity gains of up to 8.7% in a single month. An additional 5% in gross profit within five weeks. Deploy "in days, not months."
These are the kinds of promises—drawn from the company's own marketing materials—that make procurement officers either lean in or roll their eyes, sometimes both. CEO Andrew Navamoni Jebasingh leads a lean outfit, between two and ten employees depending on how you count, and the team has been working the conference circuit hard. They showed up at Nashville's Manufacturing & Automation eXchange in March, snagged a booth at Automate 2026, and secured Bronze membership in the Association for Advancing Automation.
All the usual signals of a startup trying to prove it belongs.
The $7 million seed round dwarfs SiteVue's earlier fundraising efforts—an $800,000 offering in December 2025 (with roughly $450,000 actually sold) and a smaller $215,000 round the same month that netted about $185,000. Leila Pirbay, listed as a director on the Form D filing, is a principal at Overture Ventures, though SiteVue hasn't disclosed who else joined the new round.
Why Now?
Perhaps the timing makes sense. Workplace injuries aren't just a human tragedy; they're an economic sinkhole. The National Safety Council pegged the cost to the U.S. economy at $176.5 billion in 2023. The Bureau of Labor Statistics logged 5,070 fatal work injuries in 2024—down 4% from the year before, but still a staggering toll. If even a fraction of those incidents could be flagged and prevented through better monitoring, the market potential is obvious.
But SiteVue isn't operating in a vacuum.
Invisible AI unveiled a "Vision Execution System" built on NVIDIA Jetson hardware in April 2026, targeting real-time line analytics. Intenseye, which leverages existing camera infrastructure for AI-powered safety monitoring, raised a hefty $64 million Series B back in February 2024. Sight Machine has been pushing what it calls "agentic manufacturing AI," with fresh announcements as recently as this spring.
The competition is well-funded and aggressive.
The Wearable Angle
Where SiteVue hopes to differentiate itself is in the form factor. Most competitors rely on fixed cameras—mounted overhead, on tripods, scattered across the factory floor. SiteVue's wearables move with the worker, capturing a first-person perspective that theoretically offers richer context.
Whether that's a meaningful advantage or just a different set of tradeoffs is still an open question. Workers might balk at wearing yet another device. Privacy concerns loom. And the data processing demands of egocentric video aren't trivial.
Still, the company claims it's already "3D printing and assembling 1,000 cases & cameras a week" out of Cool Springs, Tennessee. That suggests some early traction, or at least serious preparation for it—though widespread customer adoption is another matter entirely.
What Comes Next
The usual startup playbook would have SiteVue using this $7 million to hire salespeople, refine the product, and chase down pilot programs with mid-sized manufacturers willing to take a chance. The company hasn't said much publicly about its roadmap, and seed-stage startups rarely do.
What's clear is that SiteVue is betting on a market hungry for solutions—one where the human cost of inaction is measured in hospital visits and the financial cost shows up on balance sheets. If the technology delivers even half of what's promised, there's room to grow.
If not, well. The factory floor is littered with gadgets that sounded great in pitch decks but never quite made it past the pilot stage.
